vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是Orthofix Medical Inc.的1.8倍（$396.1M vs $219.9M），COMPASS MINERALS INTERNATIONAL INC净利率更高（4.7% vs -1.0%，领先5.7%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-59.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 4.3%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
CMP vs OFIX — 直观对比
营收规模更大
CMP
是对方的1.8倍
$219.9M
营收增速更快
CMP
高出27.0%
2.0%
净利率更高
CMP
高出5.7%
-1.0%
自由现金流更多
OFIX
多$76.6M
$-59.8M
两年增速更快
OFIX
近两年复合增速
4.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $219.9M |
| 净利润 | $18.6M | $-2.2M |
| 毛利率 | 16.0% | 71.1% |
| 营业利润率 | 9.2% | 0.2% |
| 净利率 | 4.7% | -1.0% |
| 营收同比 | 28.9% | 2.0% |
| 净利润同比 | 178.8% | 92.4% |
| 每股收益（稀释后） | $0.43 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMPOFIX
| Q4 25 | $396.1M | $219.9M | ||
| Q3 25 | $227.5M | $205.6M | ||
| Q2 25 | $214.6M | $203.1M | ||
| Q1 25 | $494.6M | $193.6M | ||
| Q4 24 | $307.2M | $215.7M | ||
| Q3 24 | $208.8M | $196.6M | ||
| Q2 24 | $202.9M | $198.6M | ||
| Q1 24 | $364.0M | $188.6M |
净利润CMPOFIX
| Q4 25 | $18.6M | $-2.2M | ||
| Q3 25 | $-7.2M | $-22.8M | ||
| Q2 25 | $-17.0M | $-14.1M | ||
| Q1 25 | $-32.0M | $-53.1M | ||
| Q4 24 | $-23.6M | $-29.1M | ||
| Q3 24 | $-48.3M | $-27.4M | ||
| Q2 24 | $-43.6M | $-33.4M | ||
| Q1 24 | $-38.9M | $-36.0M |
毛利率CMPOFIX
| Q4 25 | 16.0% | 71.1% | ||
| Q3 25 | 16.9% | 72.2% | ||
| Q2 25 | 19.2% | 68.7% | ||
| Q1 25 | 15.5% | 62.8% | ||
| Q4 24 | 11.2% | 69.0% | ||
| Q3 24 | 9.3% | 68.7% | ||
| Q2 24 | 16.1% | 67.8% | ||
| Q1 24 | 19.7% | 67.5% |
营业利润率CMPOFIX
| Q4 25 | 9.2% | 0.2% | ||
| Q3 25 | 5.3% | -8.3% | ||
| Q2 25 | 7.4% | -7.9% | ||
| Q1 25 | -0.6% | -25.2% | ||
| Q4 24 | 0.2% | -5.3% | ||
| Q3 24 | -14.3% | -9.6% | ||
| Q2 24 | 2.9% | -12.5% | ||
| Q1 24 | -10.8% | -15.6% |
净利率CMPOFIX
| Q4 25 | 4.7% | -1.0% | ||
| Q3 25 | -3.2% | -11.1% | ||
| Q2 25 | -7.9% | -6.9% | ||
| Q1 25 | -6.5% | -27.4% | ||
| Q4 24 | -7.7% | -13.5% | ||
| Q3 24 | -23.1% | -13.9% | ||
| Q2 24 | -21.5% | -16.8% | ||
| Q1 24 | -10.7% | -19.1% |
每股收益（稀释后）CMPOFIX
| Q4 25 | $0.43 | $-0.05 | ||
| Q3 25 | — | $-0.57 | ||
| Q2 25 | $-0.41 | $-0.36 | ||
| Q1 25 | $-0.77 | $-1.35 | ||
| Q4 24 | $-0.57 | $-0.76 | ||
| Q3 24 | $-1.17 | $-0.71 | ||
| Q2 24 | $-1.05 | $-0.88 | ||
| Q1 24 | $-0.94 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $82.0M |
| 总债务越低越好 | $890.0M | — |
| 股东权益账面价值 | $260.5M | $450.0M |
| 总资产 | $1.5B | $850.6M |
| 负债/权益比越低杠杆越低 | 3.42× | — |
8季度趋势，按日历期对齐
现金及短期投资CMPOFIX
| Q4 25 | $46.7M | $82.0M | ||
| Q3 25 | $59.7M | $62.9M | ||
| Q2 25 | $79.4M | $65.6M | ||
| Q1 25 | $49.5M | $58.0M | ||
| Q4 24 | $45.8M | $83.2M | ||
| Q3 24 | $20.2M | $30.1M | ||
| Q2 24 | $12.8M | $26.4M | ||
| Q1 24 | $38.3M | $27.0M |
总债务CMPOFIX
| Q4 25 | $890.0M | — | ||
| Q3 25 | $839.8M | $157.2M | ||
| Q2 25 | $833.4M | $157.0M | ||
| Q1 25 | $807.6M | $156.9M | ||
| Q4 24 | $974.4M | $157.0M | ||
| Q3 24 | $921.2M | $118.5M | ||
| Q2 24 | $875.1M | $118.0M | ||
| Q1 24 | $877.2M | $118.2M |
股东权益CMPOFIX
| Q4 25 | $260.5M | $450.0M | ||
| Q3 25 | $234.1M | $442.5M | ||
| Q2 25 | $249.8M | $458.3M | ||
| Q1 25 | $236.5M | $458.3M | ||
| Q4 24 | $263.0M | $503.1M | ||
| Q3 24 | $316.6M | $525.9M | ||
| Q2 24 | $352.1M | $546.0M | ||
| Q1 24 | $400.4M | $570.3M |
总资产CMPOFIX
| Q4 25 | $1.5B | $850.6M | ||
| Q3 25 | $1.5B | $832.6M | ||
| Q2 25 | $1.5B | $837.2M | ||
| Q1 25 | $1.5B | $823.1M | ||
| Q4 24 | $1.7B | $893.3M | ||
| Q3 24 | $1.6B | $867.9M | ||
| Q2 24 | $1.6B | $882.0M | ||
| Q1 24 | $1.7B | $906.0M |
负债/权益比CMPOFIX
| Q4 25 | 3.42× | — | ||
| Q3 25 | 3.59× | 0.36× | ||
| Q2 25 | 3.34× | 0.34× | ||
| Q1 25 | 3.41× | 0.34× | ||
| Q4 24 | 3.70× | 0.31× | ||
| Q3 24 | 2.91× | 0.23× | ||
| Q2 24 | 2.49× | 0.22× | ||
| Q1 24 | 2.19× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $16.8M |
| 自由现金流率自由现金流/营收 | -15.1% | 7.6% |
| 资本支出强度资本支出/营收 | 5.8% | 4.9% |
| 现金转化率经营现金流/净利润 | -1.99× | — |
| 过去12个月自由现金流最近4个季度 | $94.1M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流CMPOFIX
| Q4 25 | $-37.0M | $27.7M | ||
| Q3 25 | $-6.9M | $12.4M | ||
| Q2 25 | $21.8M | $11.6M | ||
| Q1 25 | $186.9M | $-18.4M | ||
| Q4 24 | $-4.1M | $23.7M | ||
| Q3 24 | $-12.7M | $11.7M | ||
| Q2 24 | $-6.8M | $9.0M | ||
| Q1 24 | $86.2M | $-18.6M |
自由现金流CMPOFIX
| Q4 25 | $-59.8M | $16.8M | ||
| Q3 25 | $-22.8M | $2.5M | ||
| Q2 25 | $3.8M | $4.5M | ||
| Q1 25 | $172.9M | $-25.1M | ||
| Q4 24 | $-25.9M | $15.2M | ||
| Q3 24 | $-33.6M | $6.3M | ||
| Q2 24 | $-21.5M | $-360.0K | ||
| Q1 24 | $56.2M | $-29.1M |
自由现金流率CMPOFIX
| Q4 25 | -15.1% | 7.6% | ||
| Q3 25 | -10.0% | 1.2% | ||
| Q2 25 | 1.8% | 2.2% | ||
| Q1 25 | 35.0% | -13.0% | ||
| Q4 24 | -8.4% | 7.0% | ||
| Q3 24 | -16.1% | 3.2% | ||
| Q2 24 | -10.6% | -0.2% | ||
| Q1 24 | 15.4% | -15.4% |
资本支出强度CMPOFIX
| Q4 25 | 5.8% | 4.9% | ||
| Q3 25 | 7.0% | 4.8% | ||
| Q2 25 | 8.4% | 3.5% | ||
| Q1 25 | 2.8% | 3.5% | ||
| Q4 24 | 7.1% | 4.0% | ||
| Q3 24 | 10.0% | 2.7% | ||
| Q2 24 | 7.2% | 4.7% | ||
| Q1 24 | 8.2% | 5.6% |
现金转化率CMPOFIX
| Q4 25 | -1.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
